The known unknowns of HPV natural history

被引:292
作者
Gravitt, Patti E. [1 ,2 ]
机构
[1] Perdana Univ Grad Sch Med, Serdang, Malaysia
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
关键词
HUMAN-PAPILLOMAVIRUS INFECTION; COTTONTAIL RABBIT PAPILLOMAVIRUS; CERVICAL-CANCER; TRANSPLANT RECIPIENTS; COST-EFFECTIVENESS; POOLED ANALYSIS; RISK-FACTORS; YOUNG-WOMEN; VIRAL-DNA; VACCINE;
D O I
10.1172/JCI57149
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The discovery that certain high-risk strains of human papillomavirus (HR-HPV) cause nearly 100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by promoting the development of viral vaccines. Although the efficacy of these vaccines has already been demonstrated, a complete understanding of viral latency and natural immunity is lacking, and solving these mysteries could help guide policies of cervical cancer screening and vaccine use. Here, we examine the epidemiological and biological understanding of the natural history of HPV infection, with an eye toward using these studies to guide the implementation of cervical cancer prevention strategies.
引用
收藏
页码:4593 / 4599
页数:7
相关论文
共 79 条
[11]   A Review of Prophylactic Human Papillomavirus Vaccines: Recommendations and Monitoring in the US [J].
Dunne, Eileen F. ;
Datta, S. Deblina ;
Markowitz, Lauri E. .
CANCER, 2008, 113 (10) :2995-3003
[12]   Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years [J].
Einstein, Mark H. ;
Baron, Mira ;
Levin, Myron J. ;
Chatterjee, Archana ;
Edwards, Robert P. ;
Zepp, Fred ;
Carletti, Isabelle ;
Dessy, Francis J. ;
Trofa, Andrew F. ;
Schuind, Anne ;
Dubin, Gary .
HUMAN VACCINES, 2009, 5 (10) :705-719
[13]   Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer [J].
Franco, EL ;
Villa, LL ;
Sobrinho, JP ;
Prado, JM ;
Rousseau, MC ;
Désy, M ;
Rohan, TE .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) :1415-1423
[14]   Human Papillomavirus Vaccines Current Status and Future Prospects [J].
Garland, Suzanne M. ;
Smith, Jennifer S. .
DRUGS, 2010, 70 (09) :1079-1098
[15]   Modelling the impact of HPV vaccines on cervical cancer and screening programmes [J].
Garnett, Geoffrey P. ;
Kim, Jane J. ;
French, Katherine ;
Goldie, Sue J. .
VACCINE, 2006, 24 :178-186
[16]   Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine [J].
Goldie, SJ ;
Kohli, M ;
Grima, D ;
Weinstein, MC ;
Wright, TC ;
Bosch, FX ;
Franco, E .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08) :604-615
[17]   A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine [J].
Goldie, SJ ;
Grima, D ;
Kohli, M ;
Wright, TC ;
Weinstein, M ;
Franco, E .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (06) :896-904
[18]   Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years [J].
Gonzalez, Paula ;
Hildesheim, Allan ;
Cecilia Rodriguez, Ana ;
Schiffman, Mark ;
Porras, Carolina ;
Wacholder, Sholom ;
Garcia Pineres, Alfonso ;
Pinto, Ligia A. ;
Burk, Robert D. ;
Herrero, Rolando .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (12) :3044-3054
[19]   Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States [J].
Grant, Linda Ahdieh ;
Dunne, Eileen F. ;
Chesson, Harrell ;
Markowitz, Lauri E. .
VACCINE, 2011, 29 (13) :2365-2370
[20]   Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis [J].
Grulich, Andrew E. ;
van Leeuwen, Marina T. ;
Falster, Michael ;
Vajdic, Claire M. .
LANCET, 2007, 370 (9581) :59-67